PMID: 15226834Mar 1, 1986Paper

Verapamil-potassium cardioplegia: a two-year experience with 470 patients

Texas Heart Institute Journal
G L Hicks

Abstract

This prospective clinical study in cardiac surgery involves a 2-year experience with verapamil-potassium cardioplegia in 470 patients. Protective benefits, associated with calcium channel blockers during cellular ischemia, have increased their utilization in cardioplegic solutions during open-heart surgery. Analysis of the group includes preoperative, intraoperative, and postoperative variables. Preoperative data encompasses age, previous myocardial infarctions, ejection fraction, cardiac index, and risk factors. Analysis of operative data includes the type of operation performed, anesthetic agents, amount of cardioplegia solution, total peripheral resistance, fluid requirements, cross-clamp time and arrhythmias during reperfusion. In this study, verapamil proved to be a safe and effective additive to standard potassium cardioplegia. Beneficial hemodynamic actions with myocardial preservative and antiarrhythmic effects were demonstrated. Although the "perfect solution" to myocardial preservation remains unknown, because of favorable experimental data and successful clinical trials, the continued use of verapamil-potassium cardioplegia appears justified.

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.